People with first-degree relatives who were repeatedly diagnosed with colorectal polyps appeared at increased risk for ...

William Blair analyst Jake Roberge has maintained their bullish stance on DT stock, giving a Buy rating today.Invest with Confidence: Follow ...

The methylation of plasma cell-free DNA (cfDNA) has emerged as a valuable diagnostic and prognostic biomarker in various cancers including colorectal cancer (CRC). Currently, there are no biomarkers ...

Cigna Group (NYSE: CI) reported its performance in the fourth quarter of 2024, with total revenues reaching $65.6 billion.

FEATURE Cigna Group stock was falling sharply after the health insurer missed quarterly earnings estimates and issued light guidance amid higher medical costs. Cigna stock dropped 9% to $276 in ...